Prognostic significance of symptomatic deep vein thrombosis in patients with acute symptomatic pulmonary embolism regarding the European Society of Cardiology mortality risk model.
BACKGROUND Deep vein thrombosis (DVT) can be symptomatic or asymptomatic in patients with acute pulmonary embolism (PE). The prognostic value of the symptomatic DVT at the presentation regarding the prognosis of PE is unknown. METHODS Data were extracted from the REgional Pulmonary Embolism Registry (REPER) which enrolled 1604 hospitalized patients after multidetector computed tomography (MDCT) diagnosed symptomatic acute PE. According to the ESC risk model, patients were classified into four subgroups. Patients who had leg edema with or without pain, and patients with leg pain and DVT confirmed by compression ultrasound were considered to have symptomatic DVT. This study aims to compare all-cause hospital mortality between patients with symptomatic DVT and patients without symptoms or signs of DVT across the PE risk stratums. RESULTS All-cause mortality in patients with symptomatic DVT compared to those who had no signs or symptoms of DVT were 2/196 (1.0%) vs 11/316 (3.5%), p=0.145, 4/129 (3.1%) vs 17/228 (7.5%), p=0.106, 14/196 (7.1%) vs 54/290 (18.6%), p<0.001 and 16/55 (29.1%) vs 51/139 (36.7%), p=0.402 in patients with low, intermediate-low, intermediate-high and high-risk PE, respectively. In multivariate analysis symptomatic DVT was associated with decreased inhospital mortality only in patients with intermediate-high PE (OR 0.320, 95%CI 0.164-0.627; p=0.001). Intermediate-high risk PE patients with symptomatic DVT who were treated with thrombolysis had significantly lower hospital mortality than patients without signs or symptoms of DVT (2.2% vs. 11.4%, p=0.003). CONCLUSIONS Intermediate-high risk PE patients with symptomatic DVT at presentation may benefit from thrombolysis and have lower hospital all-cause mortality in such circumstances.